Evidence map›Paper›PMID 36500985›Full record

ArticleNutrients2022

Erythrocyte Membrane Docosahexaenoic Acid (DHA) and Lipid Profile in Preterm Infants at Birth and Over the First Month of Life: A Comparative Study with Infants at Term.

Félix Castillo Salinas, Alicia Montaner Ramón, Félix-Joel Castillo Ferrer, Adrià Domingo-Carnice, Begoña Cordobilla, Joan Carles Domingo

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06366893 (Enteral Supplementation With Docosahexaenoic Acid and Arachidonic Acid), which is not on this map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06366893 naunknown statusnot on this mapstarted 2024, after this paper: background citation

Enteral Supplementation With Docosahexaenoic Acid and Arachidonic Acid (DHA-AA) in Preterm Infants. Single-center, Prospective, Randomized, Controlled, Open-label Clinical Trial

TypeinterventionalSponsorHospital Universitari Vall d'Hebron Research InstituteRan2024 to 2025Enrolled80ConditionsInfant, Premature, DiseasesArmsDHA/AA emulsion supplement for preterm infant
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Lipid metabolism and inflammation as key drivers in preterm birth: A comprehensive analysis.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Félix Castillo SalinasService of Neonatology, Hospital Universitari Vall d'Hebron, Universitat Autónoma de Barcelona, E-08035 Barcelona, Spain.
Alicia Montaner RamónService of Neonatology, Hospital Universitari Vall d'Hebron, Universitat Autónoma de Barcelona, E-08035 Barcelona, Spain.ORCID 0000-0002-7327-0066
Félix-Joel Castillo FerrerService of Neonatology, Hospital Universitari Vall d'Hebron, Universitat Autónoma de Barcelona, E-08035 Barcelona, Spain.
Adrià Domingo-CarniceDepartment of Clinical Pharmacology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, E-08907 Barcelona, Spain.
Begoña CordobillaDepartment of Biochemistry and Molecular Biomedicine, Faculty of Biology, Universitat de Barcelona, Avinguda Diagonal 643, E-08028 Barcelona, Spain.
Joan Carles DomingoDepartment of Biochemistry and Molecular Biomedicine, Faculty of Biology, Universitat de Barcelona, Avinguda Diagonal 643, E-08028 Barcelona, Spain.ORCID 0000-0002-6356-0836
Universitat Autònoma de Barcelona · ESUniversitat de Barcelona · ESBellvitge University Hospital · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An observational comparative study was designed to assess the fatty acids profile in erythrocyte membrane phospholipids of 30 preterm neonates (<32 weeks gestation) at birth and after 1 month of life versus a convenience sample of 10 infants born at term. The panel of fatty acids included the families and components of saturated fatty acids (SFAs), monounsaturated fatty acids (MUFAs), and n-6 and n-3 polyunsaturated fatty acids (PUFAs) as well as enzyme activity indexes and fatty acids ratios. At birth, the comparison of fatty acid families between preterm and term neonates showed a significantly higher content of SFAs and n-6 PUFAs, and a significantly lower content of MUFAs and n-3 PUFAs in the preterm group. After 30 days of life, significantly higher levels of n-6 PUFAs and significantly lower levels of n-3 PUFAs among preterm neonates persisted. At 30 days of birth, n-6 PUFA/n-3 PUFA and arachidonic acid (ARA) ARA/DHA remained significantly elevated, and DHA sufficiency index significantly decreased in the preterm group. The pattern of n-3 PUFA deficiency at birth and sustained for the first month of life would support the need of milk banking fortified with DHA and the use of DHA supplementation in breastfeeding mothers.

Indexed as

Docosahexaenoic AcidsFatty Acids, Omega-3Erythrocyte MembraneFatty AcidsFatty Acids, Omega-6HumansInfantInfant, NewbornInfant, PrematureMilk, HumanDocosahexaenoic AcidsFatty AcidsFatty Acids, Omega-3Fatty Acids, Omega-6arachidonic aciddocosahexaenoic acideicosapentaenoic aciderythrocyte membranelinoleic acidlipid profilepreterm infants

Identifiers

PMID36500985
PMCPMC9740272
OpenAlexW4309722648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.